Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients

Table 4

Ocular adverse events during follow-up.

Ocular adverse effects	Nepafenac group; ()	Control group; ()
Blurred vision	5 (16.7%)	3 (10%)
Foreign body sensation	2 (6.7%)	1 (3.3%)
Itching	2 (6.7%)	1 (3.3%)
Eye pain	1 (3.3%)	1 (3.3%)
Eye discharge	1 (3.3%)	2 (6.7%)
Chronic redness	3 (10%)	3 (10%)
Conjunctivitis	0	1 (3.3%)
Punctate keratitis	0	0